Cardiovascular risk stratification of diabetic patients

Minerva Endocrinologica

Volumn 34, Issue 3, 2009, Pages 205-221

  Cuocolo, A ^a,b   Concilio, C ^c   Acampa, W ^a,b   Ferro, A ^a,b   Evangelista, L ^c   Daniele, S ^c   Petretta, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Cardiac gated imaging techniques; Diabetes mellitus; Prognosis

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; HEART CATHETERIZATION; HEART SCINTISCANNING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; PREDICTION AND FORECASTING; SCINTISCANNING;

CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT;

EID: 77949904073     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000;23:1278-83.
2. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F et al. The continuing increase of diabetes in the US. Diabetes Care 2001;24:412.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
4. Diabetes Research Working Group. Conquering Diabetes: A Strategic Plan for the 21st Century. Bethesda, Md: National Institutes of Health; 1999. NIH publication No. 99-4398.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10:S1-S10. (Pubitemid 39128338)
6. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(Suppl. 2):S14-S21. (Pubitemid 32844108)
7. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992;20:736-44.
8. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 2000:36:355-65. (Pubitemid 30627410)
9. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)
11. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998;21:1551-9.
12. Miettinen H, Lehto S, Salomaa V, Mähönen M, Niemelä M, Haffner SM et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.
13. Haffner SM. Coronary heart disease in patients with diabetes. New Engl J Med 2000;342:1040-2.
14. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
15. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000;133:81-91.
16. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low-density lipoprotein cholesterol levels. J Am Coll Cardiol 1996:28:573-9.
17. Storto G, Pellegrino T, Sorrentino AR, Luongo L, Petretta M, Cuocolo A. Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. J Nucl Cardiol 2007;14:194-9. (Pubitemid 46444676)
18. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care 1999;22:1396-400.
19. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 1990;301:92-5.
20. Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S et al. Silent myocardial ischemia in patients with noninsulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992;123:46-53.
21. Nesto RW. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999;22:1393-5.
22. Cooper S, Caldwell JH. Coronary artery disease in people with diabetes: diagnostic and risk factor evaluation. Clin Diabetes 1999;17:58-82.
23. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954-61.
24. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
25. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43. (Pubitemid 28090682)
26. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70. (Pubitemid 23256923)
27. Shaw LJ, Hachamovitch R, Heller GV, Marwick TH, Travin MI, Iskandrian AE et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group. Am J Cardiol 2000;86:1-7.
28. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823-9.
29. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.
30. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005;45:50-3.
31. Diamond GA, Staniloff HM, Forrester JS, Pollok BH, Swan HJC. Computer assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
32. Acampa W, Evangelista L, Petretta M, Liuzzi R, Cuocolo A. Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events. Am J Cardiol 2007;100:436-41.
33. Acampa W, Petretta M, Evangelista L, Nappi G, Luongo L, Petretta MP et al. Stress cardiac single-photon emission computed tomographic imaging late after coronary artery bypass surgery for risk stratification and estimation of time to cardiac events. J Thorac Cardiovasc Surg 2008;136:46-51.
34. Petretta M, Acampa W, Evangelista L, Daniele S, Ferro A, Cuocolo A; Impact of Inducible Ischemia by Stress SPECT (IDIS) Investigators. Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: rationale and design of a prospective, multicenter trial. J Nucl Cardiol 2008;15:100-4.
35. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Finn SD, Gardin JM et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999;99:2829-48.
36. Raggi P, Bellasi A, Ratti C. Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management. Diabetes Care 2005;28:2787-94. (Pubitemid 43951178)
37. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-21.
38. Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 1999;100:1521-7.
39. Wackers FJ. Diabetes and coronary artery disease: the role of stress myocardial perfusion imaging. Cleve Clin J Med 2005;72:21-33.
40. Bax JJ, Van der Wall EE, De Roos A, Poldermans D. State of the art and future directions. In Clinical Nuclear Cardiology. 3rd ed. Zaret Bl, Beller GA, Eds. Philadelphia, Mosby; 2005. p. 535-55.
41. Picano E, Bedetti G, Varga A, Cseh E. The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: a meta-analysis. Coron Artery Dis 2000;11:151-9. (Pubitemid 30193054)
42. Ferro A, Pellegrino T, Spinelli L, Acampa W, Petretta M, Cuocolo A. Comparison between dobutamine echocardiography and single-photon emission computed tomography for interpretive reproducibility. Am J Cardiol 2007;100:1239-44. (Pubitemid 47498281)
43. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD. Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography. Coron Artery Dis 1997;8:171-4. (Pubitemid 27281081)
44. Dakik HA, Mahmarian JJ, Kimball KT, Koutelou MG, Medrano R, Verani MS. Prognostic value of exercise Tl-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996;94:2735-42. (Pubitemid 26411736)
45. Chiamvimonvat V, Goodman SG, Langer A, Barr A, Freeman MR. Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction. J Nucl Cardiol 2001;8:136-43. (Pubitemid 32396727)
46. Spinelli L, Petretta M, Acampa W, He W, Petretta A, Bonaduce D et al. Prognostic value of combined assessment of regional left ventricular function and myocardial perfusion by dobutamine and rest gated SPECT in patients with uncomplicated acute myocardial infarction. J Nucl Med 2003;44:1023-9.
47. Elhendy A, Schinkel AFL, van Domburg RT, Bax JJ, Poldermans D. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi single-photon emission computed tomography. Am J Cardiol 2003;91:264-8. (Pubitemid 36143863)
48. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol 1997;30:83-90. (Pubitemid 27357129)
49. Olmos LI, Dakik H, Gordon R, Dunn JK, Verani MS, Quiñones MA et al. Long-term prognostic value of exercise echocardiography compared with exercise Tl-201, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998;98:2679-86.
50. Hoque A, Maaieh M, Longaker RA, Stoddard MF. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr 2002;15:1326-34.
51. Acampa W, Spinelli L, Petretta M, De Lauro F, Ibello F, Cuocolo A. Prognostic value of myocardial ischemia in patients with uncomplicated acute myocardial infarction: direct comparison of stress echocardiography and myocardial perfusion imaging. J Nucl Med 2005;46:417-23. (Pubitemid 43093149)
52. Acampa W, Spinelli L, Petretta M, Salvatore M, Cuocolo A. Comparison of prognostic value of negative dobutamine stress echocardiography versus single-photon emission computed tomography after acute myocardial infarction. Am J Cardiol 2005;96:13-6. (Pubitemid 40853931)
53. Hung M-J, Wang C-H, Cherng W-J. Can dobutamine stress echocardiography predict cardiac events in non-revascularized diabetic patients following acute myocardial infarction? Chest 1999;116:1224-32.
54. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002;25:1042-8. (Pubitemid 41110491)
55. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 2001;37:1551-7.
56. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 2001;24:1596-601. (Pubitemid 33716455)
57. Sozzi FB, Elhendy A, Roelandt JR, Van Domburg RT, Schinkel AF, Vourvouri EC et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 2003;26:1074-8.
58. D'Andrea A, Severino S, Caso P, De Simone L, Liccardo B, Forni A et al. Prognostic value of pharmacological stress echocardiography in diabetic patients. Eur J Echocardiogr 2003;4:202-8.
59. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J 2002;143:163-8.
60. Cuocolo A, Acampa W, Imbriaco M, De Luca, Iovino GL, Salvatore M. The many ways to myocardial perfusion imaging. Q J Nucl Med Mol Imaging 2005;49:4-18.
61. Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P et al. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol 1996;3:194-203.
62. DePuey EG, Berman DS, Garcia EV. Cardiac SPECT imaging. Philadelphia: Lippincott-Raven, 1996.
63. Leppo J, Meerdink D. Comparison of the myocardial uptake of a technetium-labeled isonitrile analog and thallium. Circ Res 1989; 65:632-9.
64. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71. (Pubitemid 24114567)
65. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV et al. Technetium-99m-1,2 bis (bis(2-ethoxyethyl)phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
66. Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998;3:265-74. (Pubitemid 28333890)
67. Leppo JA. Comparison of pharmacologic stress agents. J Nucl Cardiol 1996;3(pt 2):S22-S26.
68. Petretta M, Costanzo P, Acampa W, Imbriaco M, Ferro A, Filardi PP et al. Noninvasive assessment of coronary anatomy and myocardial perfusion: going toward an integrated imaging approach. J Cardiovasc Med 2008;9:977-86.
69. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004;2:261-91.
70. Bateman TM, Cullom SJ. Attenuation correction single-photon emission computed tomography myocardial perfusion imaging. Semin Nucl Med 2005;1:37-51. (Pubitemid 40092314)
71. Danias PG, Ahlberg AW, Clark BA 3rd, Messineo F, Levine MG, McGill CC et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1998;82:1253-8.
72. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999;137:949-57. (Pubitemid 29226307)
73. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62. (Pubitemid 28351042)
74. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71. (Pubitemid 16164371)
75. Machecourt J, Longère P, Fagret D, Vanzetto G, Wolf JE, Polidori C et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to the extent of myocardial defect: study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994;23:1096-106.
76. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999:100:1035-42.
77. Kang X, Barman DS, Lewin HC, Cohen I, Friedman JD, Germano G et al. Incremental prognostic value of myocardial perfusion single photon emission computer tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-32.
78. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 1995;92:2157-62.
79. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004;164:126-8.
80. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-9.
81. Bax JJ, Beanlands RS, Klocke FJ, Knuuti J, Lammertsma AA, Schaefers MA et al. Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? Heart 2007;93:16-22.
82. Bischof Delaloye A, Carrio I, Cuocolo A, Gourtsoyiannis N, Knapp W, McCall I et al. White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging. Eur J Nucl Med Mol Imaging 2007;34:1147-51.
83. Kalki K, Blankespoor SC, Brown JK, Hasegawa BH, Dae MW, Chin M et al. Myocardial perfusion imaging with a combined x-ray CT and SPECT system. J Nucl Med 1997;10:1535-40.
84. Wallis JW, Miller TR, Koppel P. Attenuation correction in cardiac SPECT without a transmission measurement. J Nucl Med 1995;3:506-12.
85. Schindler TH, Magosaki N, Jeserich M, Oser U, Krause T, Fischer R et al. Fusion imaging: combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease. Int J Card Imaging 1999;15:357-68. (Pubitemid 32132728)
86. Schindler TH, Magosaki N, Jeserich M, Nitzsche E, Oser U, Abdollahnia T et al. 3D assessment of myocardial perfusion parameter combined with 3D reconstructed coronary artery tree from digital coronary angiograms. Int J Card Imaging 2000;16:1-12. (Pubitemid 30218795)
87. Faber TL, Santana CA, Garcia EV, Candell-Riera J, Folks RD, Peifer JW et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation. J Nucl Med 2004;45:745-53. (Pubitemid 47618551)
88. Nakaura T, Utsunomiya D, Shiraishi S, Tomiguchi S, Honda T, Ogawa H et al. Three-dimensional cardiac image fusion using new CT angiography and SPECT methods. AJR Am J Roentgenol 2005;185:1554-7.
89. Di Carli MF, Dorbala S, Curillova Z, Kwong RJ, Goldhaber SZ, Rybicki FJ et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol 2007;14:799-809. (Pubitemid 350103056)